Antiarrhythmic peptide has no direct cardiac actions
- 1 August 1989
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 45 (8) , 737-738
- https://doi.org/10.1007/bf01974573
Abstract
The electrophysiologic, inotropic, and muscarinic effects of antiarrhythmic, peptide (AAP) were examined in canine cardiac Purkinje fibers, ferret papillary muscle, and canine cardiac membranes, respectively. Aside from a prolongation of time to peak force, in papillary muscle, no biologically significant effects of AAP could be determined in any, preparation, suggesting that its antiarrhythmic, effects are not mediated by direct membrane actions.This publication has 7 references indexed in Scilit:
- Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agentsJournal of Medicinal Chemistry, 1987
- Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agentsJournal of Medicinal Chemistry, 1987
- RESPONSE OF IMMUNOREACTIVE ANTIARRHYTHMIC PEPTIDE (IR-AAP) LEVEL ASSOCIATED WITH EXPERIMENTAL ARRHYTHMIA IN RATSJournal of Pharmacobio-Dynamics, 1986
- Studies on heart. XXIV. Inhibitory effect of antiarrhythmic peptide (AAP) on experimental thromboses.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Central neurotransmitter receptors in hypertensive ratsLife Sciences, 1981
- Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Studies on heart. XX. Further effects of bovine ventricle protein (BVP) and antiarrhythmic peptide (AAP) on myocardial cells in culture.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980